Esperion(ESPR) - 2022 Q1 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Tiffany Aldrich - Senior Manager, Corporate Communications Sheldon Koenig - President and Chief Executive Officer Joanne Foody - Chief Medical Officer Eric Warren - Chief Commercial Officer BJ Swartz - Chief Strategy Officer Conference Call Participants Serge Belanger - Needham Jason Butler - JMP Securities Jessica Fye - JPMorgan Jeff Hung - Morgan Stanley Joseph Thome - Cowen Paul Choi - G ...